Table: Hisamitsu -2025/26 group results

Hisamitsu Pharmaceutical Co

13/04/2026 07:30

Apr 13 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 28, 2026    Feb 28, 2025   Feb 28, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            163.02          156.01                                
                 (+4.5 pct)      (+10.1 pct)                             
  Operating         17.92           18.90                                
                 (-5.2 pct)      (+43.5 pct)                             
  Recurring         23.95           24.01                                
                 (-0.2 pct)      (+22.2 pct)                             
  Net
  Net               19.16           21.76                                
                 (-11.9 pct)     (+55.8 pct)                             
  EPS            268.56 yen      295.57 yen                              
  EPS Diluted    268.22 yen      295.15 yen                              
  Ann Div         60.00 yen       90.00 yen                              
  -Q2 Div         60.00 yen       45.00 yen                              
  -Q4 Div            NIL          45.00 yen                              
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T